Vita Life Sciences Limited (AU:VLS)
ASX:VLS
Total Valuation
Vita Life Sciences Limited has a market cap or net worth of AU$136.69M. The enterprise value is AU$102.76M.
Market CapAU$136.69M
Enterprise ValueAU$102.76M
Share Statistics
Vita Life Sciences Limited has 54,458,700 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding54,458,700
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Vita Life Sciences Limited’s return on equity (ROE) is 0.19 and return on invested capital (ROIC) is 18.05%.
Return on Equity (ROE)0.19
Return on Assets (ROA)0.13
Return on Invested Capital (ROIC)18.05%
Return on Capital Employed (ROCE)0.25
Revenue Per Employee233.18K
Profits Per Employee26.09K
Employee Count400
Asset Turnover1.13
Inventory Turnover2.47
Valuation Ratios
The current PE Ratio of Vita Life Sciences Limited is 13.8. Vita Life Sciences Limited’s PEG ratio is 0.74.
PE Ratio13.8
PS Ratio1.55
PB Ratio2.57
Price to Fair Value2.57
Price to FCF9.11
Price to Operating Cash Flow8.52
PEG Ratio0.74
Income Statement
In the last 12 months, Vita Life Sciences Limited had revenue of 93.27M and earned 10.44M in profits. Earnings per share was 0.19.
Revenue93.27M
Gross Profit56.03M
Operating Income14.66M
Pretax Income14.43M
Net Income10.44M
EBITDA15.66M
Earnings Per Share (EPS)0.19
Cash Flow
In the last 12 months, operating cash flow was 16.43M and capital expenditures -570.00K, giving a free cash flow of 15.86M billion.
Operating Cash Flow16.43M
Free Cash Flow15.86M
Free Cash Flow per Share0.29
Dividends & Yields
Vita Life Sciences Limited pays an annual dividend of AU$0.045, resulting in a dividend yield of 4.33%
Dividend Per ShareAU$0.045
Dividend Yield4.33%
Payout Ratio66.27%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-0.10
52-Week Price Change40.77%
50-Day Moving Average2.47
200-Day Moving Average2.34
Relative Strength Index (RSI)53.04
Average Volume (3m)14.76K
Important Dates
Vita Life Sciences Limited upcoming earnings date is Aug 20, 2026, TBA (Confirmed).
Last Earnings DateFeb 16, 2026
Next Earnings DateAug 20, 2026
Ex-Dividend Date―
Financial Position
Vita Life Sciences Limited as a current ratio of 2.72, with Debt / Equity ratio of 7.65%
Current Ratio2.72
Quick Ratio2.10
Debt to Market Cap0.02
Net Debt to EBITDA-2.00
Interest Coverage Ratio41.52
Taxes
In the past 12 months, Vita Life Sciences Limited has paid 4.00M in taxes.
Income Tax4.00M
Effective Tax Rate0.28
Enterprise Valuation
Vita Life Sciences Limited EV to EBITDA ratio is 7.23, with an EV/FCF ratio of 7.14.
EV to Sales1.21
EV to EBITDA7.23
EV to Free Cash Flow7.14
EV to Operating Cash Flow6.89
Balance Sheet
Vita Life Sciences Limited has AU$35.56M in cash and marketable securities with AU$4.30M in debt, giving a net cash position of AU$31.26M billion.
Cash & Marketable SecuritiesAU$35.56M
Total DebtAU$4.30M
Net CashAU$31.26M
Net Cash Per ShareAU$0.57
Tangible Book Value Per ShareAU$1.00
Margins
Gross margin is 61.15%, with operating margin of 15.71%, and net profit margin of 11.19%.
Gross Margin61.15%
Operating Margin15.71%
Pretax Margin15.47%
Net Profit Margin11.19%
EBITDA Margin16.80%
EBIT Margin15.71%
Analyst Forecast
The average price target for Vita Life Sciences Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast8.46%
EPS Growth Forecast-1.95%